archive-com.com » COM » I » ISIS-INNOVATION.COM

Total: 451

Choose link from "Titles, links and description words view":

Or switch to "Titles and links view".
  • Isis Innovation spinouts - Isis Innovation
    Contact Us News Events Publications News Events Request further information Technology Showcase 2016 Success Stories Publications Annual Reports Innovation Insights Isis newsletters Comment opinion Other publications reports Home Investment Opportunities Isis Innovation spinouts Share this Started in Oxford Since 1997 Isis Innovation has been responsible for creating spin out companies based on academic research generated within and owned by the University of Oxford and has spun out a new company every two months on average Over 266 million in external investment has been raised by Isis spin out companies since 2000 and five are currently listed on London s AIM market The creation of these new spin out companies also channels millions of pounds back into University research benefits local economic development and has created many new jobs in the region DATE NAME ORIGIN Export List 2014 NightStar A private biopharmaceutical company focused on the development of therapies for retinal dystrophies Incorporated in January 2014 https www nightstarx com https www nightstarx com Origin Oxford University Nuffield Department of Clinical Neurosciences 2013 Oxford Mestar A rapidly grown energetic company specializing in translational and regenerative medicine Incorporated in December 2013 http www oxford mestar com http www oxford mestar com Origin Oxford University Institute of Biomedical Engineering Oxford Biotrans Develops and commercialises enzymatic process technologies that yield high value chemical compounds Incorporated in September 2013 http oxfordbiotrans com http oxfordbiotrans com Origin Oxford University Department of Chemistry Perspectum Diagnostics Developing solutions for major unmet needs in diagnostic medicine in multiple internal organs In the first instance the focus will be on the detection and the accurate quantitative measurement of liver gallbladder and pancreatic disease including precancerous and cancerous states in these organs Incorporated in April 2013 http perspectum diagnostics com http perspectum diagnostics com Origin Oxford University Department of Cardiovascular Medicine 2012 Run3D Offering the most accurate assessment of running biomechanics that modern science is able to provide Incorporated in December 2012 http www run3d co uk http www run3d co uk Origin Oxford University Department of Engineering Science Oxford VacMedix Cellular immunity vaccines Incorporated in September 2012 Origin Oxford University Weatherall Institute of Molecular Medicine Oxehealth Revolutionary healthcare technology that measures medical vital signs without physical contact Incorporated in August 2012 http www oxehealth com http www oxehealth com Origin Oxford University Institute of Biomedical Engineering Intelligent Ultrasound Intelligent Ultrasound develops and sells products and services that make medical ultrasound imaging a more effective diagnostic tool and help hospitals provide a better quality more consistent ultrasound imaging service for their patients Incorporated in July 2012 intelligentultrasound com intelligentultrasound com Origin Oxford University Institute of Biomedical Engineering 2011 Oxford Cancer Biomarkers Pioneering biomarker technologies for cancer therapies Incorporated in December 2011 http www oxfordbio com http www oxfordbio com Origin Oxford University Department of Oncology Oxford Imaging Detectors Developing high performance scientific imaging detectors capable of studying structures and processes at the atomic level Incorporated in October 2011 Origin Oxford University Department of Materials Oxford Multi Spectral Develops and manufacturers multispectral

    Original URL path: http://isis-innovation.com/investment-opportunities/spin-outs/page/2/ (2016-05-01)
    Open archived version from archive


  • Isis Innovation spinouts - Isis Innovation
    in Oxford Since 1997 Isis Innovation has been responsible for creating spin out companies based on academic research generated within and owned by the University of Oxford and has spun out a new company every two months on average Over 266 million in external investment has been raised by Isis spin out companies since 2000 and five are currently listed on London s AIM market The creation of these new spin out companies also channels millions of pounds back into University research benefits local economic development and has created many new jobs in the region DATE NAME ORIGIN Export List 2009 Oxford Financial Computing Incorporated in March 2009 Origin Oxford University Department of Mathematics Oxford e Research Centre 2008 Organox The OrganOx metra is the first and only fully automated normothermic liver perfusion device for improved organ preservation The OrganOx pipeline products will extend the use of their core technology to the preservation of other organs Incorporated in November 2008 http www organox com http www organox com Origin Oxford University Institute of Biomedical Engineering Nuffield Department of Surgical Sciences Nevatas Navetas is a UK based technology company delivering cloud based energy monitoring and smart data analytics for the connected home Incorporated in November 2008 http www navetas com http www navetas com Origin Oxford University Department of Engineering Science Oxford Emergent TB Consortium Ltd New tuberculosis vaccine MVA85A Incorporated in July 2008 Semmle SemmleCode is a line of products aimed to help developer teams improve their software quality Incorporated in March 2008 https semmle com https semmle com Origin Oxford University Department of Computer Science 2007 Crysalin Crysalin develop a protein lattice technology that is founded on a novel form of highly ordered materials crysalins that are produced through modification of naturally occurring protein building blocks Incorporated in June 2007 http www crysalin com http www crysalin com Origin Oxford University Department of Biochemistry Oxford Biodynamics Oxford BioDynamics offers a novel and revolutionary biomarker discovery platform technology in the diagnostics field of aberrant gene expression Incorporated in June 2007 http oxfordbiodynamics com http oxfordbiodynamics com Origin Oxford University Department of Pathology Clinox ClinOx offers clients knowledge and expertise in the development placement conduct and analysis of early phase oncology clinical trials with particular emphasis on pharmacokinetic and mechanistic endpoints Incorporated in June 2007 Origin Oxford University Nuffield Division of Clinical and Laboratory Sciences Eykona Eykona develops state of art imaging solutions to capture dermal characteristics and shape from the human body Incorporated in February 2007 https www fuel 3d com eykona https www fuel 3d com eykona Origin Oxford University Department of Engineering Science 2006 OxTox Oxtox develops medical devices for the detection of specific drugs in the human system Incorporated in November 2006 Origin Oxford University Department of Chemistry Cytox Cytox develops a technology platform for tests to identify individuals at risk of cognitive decline Alzheimer s disease and other dementias Incorporated in October 2006 http www cytoxgroup com http www cytoxgroup com Origin Oxford University Division of

    Original URL path: http://isis-innovation.com/investment-opportunities/spin-outs/page/3/ (2016-05-01)
    Open archived version from archive

  • Isis Innovation spinouts - Isis Innovation
    News Incubator Services Stages of Development Our Ventures Meet the CEOs Find your CEO match Incubator Team Contact For University Members Consulting Services Support FAQs Register as a consultant Commercialising Your Technology IP patents and licences Starting a company FAQs Isis Startup Incubator Oxford University Hospital NHS Foundation Trust Translational Funding University Hot Desks For Medical Sciences Researchers Contact Us News Events Publications News Events Request further information Technology Showcase 2016 Success Stories Publications Annual Reports Innovation Insights Isis newsletters Comment opinion Other publications reports Home Investment Opportunities Isis Innovation spinouts Share this Started in Oxford Since 1997 Isis Innovation has been responsible for creating spin out companies based on academic research generated within and owned by the University of Oxford and has spun out a new company every two months on average Over 266 million in external investment has been raised by Isis spin out companies since 2000 and five are currently listed on London s AIM market The creation of these new spin out companies also channels millions of pounds back into University research benefits local economic development and has created many new jobs in the region DATE NAME ORIGIN Export List 2005 Oxford Nanopore Technologies Oxford Nanopore Technologies is developing and commercialising a new generation of nanopore based electronic systems for analysis of single molecules including DNA RNA and proteins Incorporated in May 2005 https www nanoporetech com https www nanoporetech com Origin Oxford University Department of Chemistry 2004 EKB Technology EKB Technology commercialises a revolutionary Bioprocessing Technology developed for the use of biological systems such as plant and animal cells and microorganisms to modify produce or purify chemical intermediates Incorporated in December 2004 Origin Oxford University Department of Earth Sciences Surface Therapeutics Surface Therapeutics is a drug discovery and development company developing innovative new drugs to treat inflammatory epithelial diseases of the skin and lungs Surface Therapeutics was acquired by Serentis Inc in September 2007 Incorporated in November 2004 Origin Oxford University Wellcome Trust Centre for Human Genetics G Nostics G Nostics has identified SNPs that have highly predictive associations with nicotine addiction and therefore tobacco consumption These SNPs provide a method to help individuals decide which specific smoking cessation methods are most effective for them offering personalised treatment to the smoker which significantly increases their chances of quitting Incorporated in June 2004 Origin Oxford University Department of Pharmacology Oxford Medical Diagnostics Oxford Medical Diagnostics develops and supplies breath analysis technologies for rapid accurate and low cost monitoring of diseases and metabolic functions Incorporated in June 2004 www omdiagnostics com www omdiagnostics com Origin Oxford University Department of Physical and Theoretical Chemistry 2003 Oxford Consultants for Social Inclusion Oxford Consultants for Social Inclusion OCSI helps local government identify deprived neighbourhoods target resources evaluate programme effectiveness and strengthen regeneration bids Incorporated in August 2003 http ocsi uk http ocsi uk Origin Oxford University Department of Social Policy and Intervention Riotech A biotherapeutics company established to exploit the work in Viral Hepatitis undertaken at Imperial College London and

    Original URL path: http://isis-innovation.com/investment-opportunities/spin-outs/page/4/ (2016-05-01)
    Open archived version from archive

  • Statistics - Isis Innovation
    Support FAQs Register as a consultant Commercialising Your Technology IP patents and licences Starting a company FAQs Isis Startup Incubator Oxford University Hospital NHS Foundation Trust Translational Funding University Hot Desks For Medical Sciences Researchers Contact Us News Events Publications News Events Request further information Technology Showcase 2016 Success Stories Publications Annual Reports Innovation Insights Isis newsletters Comment opinion Other publications reports About Groups People Overview Board Overview Networks Oxford Innovation Society Isis Angels Network Other Networks Isis Innovation in China Jobs Other Languages Contact us Technologies Available Explore Technologies for License Intellectual Property IP for SMEs Material Reagent Sales Easy to use Materials Evaluation Agreement Investment Opportunities Technology investment opportunities Information for Investors Isis Innovation spinouts Oxford Invention Fund University of Oxford Isis Funds Oxford University Consulting Services Academic consulting advice Academic Expertise Showcases Technical Services Technical Services Showcases OUC Clients For University members Contact OUC Innovation Consultancy Technology Transfer Commercialisation Training Technology Transfer Services Technology Commercialisation Innovation Management Case Study Overview Contact us Health Outcomes iOutcomes People Overview Clinical Outcomes Assessments Health Outcome Services FAQs Apply to Use Inspired Works Contact us Incubator News Incubator Services Stages of Development Our Ventures Meet the CEOs Find your CEO match Incubator Team Contact For University Members Consulting Services Support FAQs Register as a consultant Commercialising Your Technology IP patents and licences Starting a company FAQs Isis Startup Incubator Oxford University Hospital NHS Foundation Trust Translational Funding University Hot Desks For Medical Sciences Researchers Contact Us News Events Publications News Events Request further information Technology Showcase 2016 Success Stories Publications Annual Reports Innovation Insights Isis newsletters Comment opinion Other publications reports Home Academic Consulting from Oxford University Academic consulting advice Statistics Share this Statistics Statisticians at Oxford can act as both analysts and advisors to help clients fully understand their data

    Original URL path: http://isis-innovation.com/academic-showcases/statistics/ (2016-05-01)
    Open archived version from archive

  • Synthetic Chemistry - Isis Innovation
    Publications Annual Reports Innovation Insights Isis newsletters Comment opinion Other publications reports About Groups People Overview Board Overview Networks Oxford Innovation Society Isis Angels Network Other Networks Isis Innovation in China Jobs Other Languages Contact us Technologies Available Explore Technologies for License Intellectual Property IP for SMEs Material Reagent Sales Easy to use Materials Evaluation Agreement Investment Opportunities Technology investment opportunities Information for Investors Isis Innovation spinouts Oxford Invention Fund University of Oxford Isis Funds Oxford University Consulting Services Academic consulting advice Academic Expertise Showcases Technical Services Technical Services Showcases OUC Clients For University members Contact OUC Innovation Consultancy Technology Transfer Commercialisation Training Technology Transfer Services Technology Commercialisation Innovation Management Case Study Overview Contact us Health Outcomes iOutcomes People Overview Clinical Outcomes Assessments Health Outcome Services FAQs Apply to Use Inspired Works Contact us Incubator News Incubator Services Stages of Development Our Ventures Meet the CEOs Find your CEO match Incubator Team Contact For University Members Consulting Services Support FAQs Register as a consultant Commercialising Your Technology IP patents and licences Starting a company FAQs Isis Startup Incubator Oxford University Hospital NHS Foundation Trust Translational Funding University Hot Desks For Medical Sciences Researchers Contact Us News Events Publications News Events Request further information Technology Showcase 2016 Success Stories Publications Annual Reports Innovation Insights Isis newsletters Comment opinion Other publications reports Home Academic Consulting from Oxford University Academic consulting advice Synthetic Chemistry Share this Synthetic Chemistry Synthesis is one of the core research themes within the world leading Department of Chemistry at Oxford Chemical synthesis forms a critical part of the pathway that supplies agrochemicals pharmaceuticals and complex materials to industries worldwide Researchers in the Department of Chemistry at Oxford are performing both fundamental and applied research in synthesis across a broad range of areas including Advanced molecular materials Biomolecular synthesis

    Original URL path: http://isis-innovation.com/academic-showcases/synthetic-chemistry/ (2016-05-01)
    Open archived version from archive

  • Genome engineering - Isis Innovation
    Contact Us News Events Publications News Events Request further information Technology Showcase 2016 Success Stories Publications Annual Reports Innovation Insights Isis newsletters Comment opinion Other publications reports About Groups People Overview Board Overview Networks Oxford Innovation Society Isis Angels Network Other Networks Isis Innovation in China Jobs Other Languages Contact us Technologies Available Explore Technologies for License Intellectual Property IP for SMEs Material Reagent Sales Easy to use Materials Evaluation Agreement Investment Opportunities Technology investment opportunities Information for Investors Isis Innovation spinouts Oxford Invention Fund University of Oxford Isis Funds Oxford University Consulting Services Academic consulting advice Academic Expertise Showcases Technical Services Technical Services Showcases OUC Clients For University members Contact OUC Innovation Consultancy Technology Transfer Commercialisation Training Technology Transfer Services Technology Commercialisation Innovation Management Case Study Overview Contact us Health Outcomes iOutcomes People Overview Clinical Outcomes Assessments Health Outcome Services FAQs Apply to Use Inspired Works Contact us Incubator News Incubator Services Stages of Development Our Ventures Meet the CEOs Find your CEO match Incubator Team Contact For University Members Consulting Services Support FAQs Register as a consultant Commercialising Your Technology IP patents and licences Starting a company FAQs Isis Startup Incubator Oxford University Hospital NHS Foundation Trust Translational Funding University Hot Desks For Medical Sciences Researchers Contact Us News Events Publications News Events Request further information Technology Showcase 2016 Success Stories Publications Annual Reports Innovation Insights Isis newsletters Comment opinion Other publications reports Home Academic Consulting from Oxford University Academic consulting advice Genome engineering Share this Genome engineering Experts at Oxford are active in genome engineering research to better understand study and treat human disease Various research programmes across the Medical Sciences Division at Oxford are exploring a range of different approaches to genome engineering for treating human disease and to develop research tools with broad application Current

    Original URL path: http://isis-innovation.com/academic-showcases/genome-engineering/ (2016-05-01)
    Open archived version from archive

  • In vitro diagnostics - Isis Innovation
    Available Explore Technologies for License Intellectual Property IP for SMEs Material Reagent Sales Easy to use Materials Evaluation Agreement Investment Opportunities Technology investment opportunities Information for Investors Isis Innovation spinouts Oxford Invention Fund University of Oxford Isis Funds Oxford University Consulting Services Academic consulting advice Academic Expertise Showcases Technical Services Technical Services Showcases OUC Clients For University members Contact OUC Innovation Consultancy Technology Transfer Commercialisation Training Technology Transfer Services Technology Commercialisation Innovation Management Case Study Overview Contact us Health Outcomes iOutcomes People Overview Clinical Outcomes Assessments Health Outcome Services FAQs Apply to Use Inspired Works Contact us Incubator News Incubator Services Stages of Development Our Ventures Meet the CEOs Find your CEO match Incubator Team Contact For University Members Consulting Services Support FAQs Register as a consultant Commercialising Your Technology IP patents and licences Starting a company FAQs Isis Startup Incubator Oxford University Hospital NHS Foundation Trust Translational Funding University Hot Desks For Medical Sciences Researchers Contact Us News Events Publications News Events Request further information Technology Showcase 2016 Success Stories Publications Annual Reports Innovation Insights Isis newsletters Comment opinion Other publications reports Home Academic Consulting from Oxford University Academic consulting advice In vitro diagnostics Share this In vitro diagnostics The National Institute for Health Research Diagnostic Evidence Cooperative Oxford NIHR DEC Oxford is at the forefront of evaluating and testing in vitro diagnostics IVDs in primary care settings The NIHR DEC Oxford at Oxford Health NHS Foundation Trust is based in the University s Nuffield Department of Primary Care Health Sciences top ranked nationally in the 2014 Research Excellence Framework exercise and host to world leaders in diagnostics and evidence based medicine research The DEC s researchers focus on the identification of unfilled niches and barriers to the implementation of IVDs in primary care and offer a number of

    Original URL path: http://isis-innovation.com/academic-showcases/vitro-diagnostics/ (2016-05-01)
    Open archived version from archive

  • Drug Discovery & Development - Isis Innovation
    Academic consulting advice Academic Expertise Showcases Technical Services Technical Services Showcases OUC Clients For University members Contact OUC Innovation Consultancy Technology Transfer Commercialisation Training Technology Transfer Services Technology Commercialisation Innovation Management Case Study Overview Contact us Health Outcomes iOutcomes People Overview Clinical Outcomes Assessments Health Outcome Services FAQs Apply to Use Inspired Works Contact us Incubator News Incubator Services Stages of Development Our Ventures Meet the CEOs Find your CEO match Incubator Team Contact For University Members Consulting Services Support FAQs Register as a consultant Commercialising Your Technology IP patents and licences Starting a company FAQs Isis Startup Incubator Oxford University Hospital NHS Foundation Trust Translational Funding University Hot Desks For Medical Sciences Researchers Contact Us News Events Publications News Events Request further information Technology Showcase 2016 Success Stories Publications Annual Reports Innovation Insights Isis newsletters Comment opinion Other publications reports Home Academic Consulting from Oxford University Academic consulting advice Drug Discovery Development Share this Drug Discovery Development The Medical Sciences Division at Oxford is home to the research expertise of more than 2500 researchers across 26 departments supported by state of the art facilities The breadth and depth of expertise and experience in the Medical Sciences offers a wealth of opportunities for those companies in the business of developing new medicines to enhance their discovery efforts and inform their development strategies across the pharmaceutical value chain Drug Discovery Understanding the fundamental biology that underpins a particular disease is critical for guiding decisions and increasing efficiency when discovering potential new therapies Oxford has world class research groups in a broad range of therapeutic areas including oncology immunology and cardiovascular disease which can be accessed through consultancy to expand knowledge bases provide fresh insight and stimulate innovation Harnessing the right technologies is also paramount for example utilising in silico modelling to

    Original URL path: http://isis-innovation.com/academic-showcases/drug-discovery-development/ (2016-05-01)
    Open archived version from archive



  •